The Research Working Group seeks to bridge the missing mile between basic research and the commercialization of products. Having an equal partnership between the Virtual Physiological Human Institute (VPH) and industries engaged in predictive medicine provides a unique opportunity to explore areas of mutual cooperation and benefit.

The key goals of this group are:

  • Promotion of in silico medicine in Horizon 2020;
  • Working towards the creation of a Public Private Partnership (PPP) on in silico medicine;
  • Creating links between the VPH Membership and Avicenna Industry Members


Priorities in 2018

→ Further develop a comprehensive position for Avicenna on what is needed in EU research;
→ Launch of the new Avicenna Alliance internship scheme;
→ A core focus of the VPH membership is on the FET Flagship on ageing and on shaping this Flagship programme;
→ Contribute to the three upcoming Avicenna Alliance White Papers

Working group leader:

  • Liesbet Geris
  • Executive Director, VPH Institute
  • Professor, University of Liège & KU Leuven (Belgium)

Avicenna Alliance news

The Commission adopted a Communication on a new European Research Area for Research and Innovation

On 30 September the European Commission adopted a Communication on a new European Research Area for...

find out more ›

CADFEM Medical ONLINE Conference 2020

Under the motto "in vivo, in vitro, in silico - the central role of in silico medicine - what it can do and what we need for it", this year's specialist...

find out more ›

Avicenna provides feedback to the survey on the pharmaceutical strategy

On 15 September the Avicenna Alliance submitted Member's feedback to the survey on the pharmaceutical strategy! While...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up